Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BIT/1SAN stock hub

BIT/1SAN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BIT/1SANis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
87.7B
Borsa Italiana
Market data

Live price

Current market quote for this ticker.

Current price
BIT/1SAN
In the news

Latest news · BIT/1SAN

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.5
P25 13P50 15.3P75 18.4
Trailing P/E11.6
P25 14.4P50 21.2P75 24.6
ROE6.6
P25 3.1P50 8.5P75 13.3
ROIC9.4
P25 5.3P50 8.5P75 15.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BIT/1SAN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
226
Groups with data
11
Currency
EUR
Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
France
Country code
IT
Employees
74,846
Employees Change
-8,032%
Employees Change Percent
-9.69
Enterprise value
EUR 102.5B
Exchange
Borsa Italiana
Financial currency
EUR
First seen
2026-05-10
Industry
Drug Manufacturers - General
Isin
FR0000120578
Last refreshed
2026-05-10
Market cap
EUR 87.7B
Price
EUR 73.02
Price currency
EUR
Rev Per Employee
632,685.78x
Sector
Healthcare
Sic
2834
Symbol
bit/1SAN
Website
https://www.sanofi.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
8.61%
EV Earnings
13.57x
EV/EBIT
10.78x
EV/EBITDA
7.94x
EV/FCF
11.95x
EV/Sales
2.17x
FCF yield
9.78%
Forward P/E
8.5x
P/B ratio
1.2x
P/E ratio
11.61x
P/S ratio
1.85x
PE Ratio10 Y
18.51x
PE Ratio3 Y
18.15x
PE Ratio5 Y
17.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
20.49%
EBITDA Margin
27.09%
FCF margin
18.11%
Gross margin
72.36%
Gross Profit
EUR 34.3B
Gross Profit Growth
6.9%
Gross Profit Growth Q
6.1%
Gross Profit Growth3 Y
1.98%
Gross Profit Growth5 Y
6.49%
Net Income
EUR 7.6B
Net Income Growth
19.94%
Net Income Growth Q
-13.78%
Net Income Growth3 Y
-3.31%
Net Income Growth5 Y
-9.14%
Pretax Margin
12.32%
Profit Margin
15.95%
Profit Per Employee
EUR 100,941
ROA
4.67
Roa5y
4.55
ROCE
9.9
ROE
6.58
Roe5y
8.3
ROIC
9.38
Roic5y
8.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

20
MetricValue
Cagr10y
5.03%
Cagr15y
6.37%
Cagr1y
-12.48%
Cagr3y
-4.74%
Cagr5y
1.18%
Div CAGR10
3.47%
Div CAGR3
4.99%
Div CAGR5
5.18%
EPS Growth
22.95
EPS Growth Q
-11.66
EPS Growth3 Y
-2.29
EPS Growth5 Y
-8.52
FCF Growth
-8.29%
FCF Growth Q
-19.59%
OCF Growth
-6.73%
OCF Growth Q
-19.59%
Revenue Growth
4.84x
Revenue Growth Q
6.02x
Revenue Growth3 Y
0.83x
Revenue Growth5 Y
5.09x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 0.36
Assets
EUR 128B
Cash
EUR 5.5B
Current Assets
EUR 30.2B
Current Liabilities
EUR 30B
Debt
EUR 20B
Debt EBITDA
EUR 1.53
Debt Equity
EUR 0.27
Debt FCF
EUR 2.33
Equity
EUR 73.1B
Interest Coverage
18.84
Liabilities
EUR 54.9B
Long Term Assets
EUR 97.9B
Long Term Liabilities
EUR 24.9B
Net Cash
EUR -14.5B
Net Cash By Market Cap
EUR -16.5
Net Debt EBITDA
EUR 1.13
Net Debt Equity
EUR 0.2
Net Debt FCF
EUR 1.69
Tangible Book Value
EUR 3.7B
Tangible Book Value Per Share
EUR 3.09
WACC
5.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.01
Inventory Turnover
0.58
Net Working Capital
EUR 793M
Quick ratio
0.2
Working Capital
EUR 156M
Working Capital Turnover
EUR 7.92

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
2.73%
Dividend Growth
5.1%
Dividend Growth Years
2%
Dividend per share
EUR 4.12
Dividend Years
20
Dividend Yield
5.25%
Ex Div Date
2026-05-05
Last Dividend
EUR 4.12
Payout Frequency
Annual
Payout Ratio
63.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
10Y total return
63.32%
1Y total return
-12.48%
200-day SMA
82.12
3Y total return
-13.55%
50-day SMA
78.94
50-day SMA vs 200-day SMA
50under200
5Y total return
6.04%
All Time High
111
All Time High Change
-34.22%
All Time High Date
2025-03-24
All Time Low
37.7
All Time Low Change
93.69%
All Time Low Date
2008-10-10
ATR
2.06
Beta
0.28
Ch YTD
-12.07
High
73.42
High52
94.9
High52 Date
2025-06-02
High52ch
-23.43%
Low
72.76
Low52
72.76
Low52 Date
2026-05-08
Low52ch
0.16%
Ma50ch
-7.5%
Price vs 200-day SMA
-11.08%
RSI
32.29
RSI Monthly
37.26
RSI Weekly
38.39
Sharpe ratio
-0.49x
Sortino ratio
-0.46
Total Return
7.98%
Tr YTD
-7.16
Tr15y
152.4%
Tr1m
-4.02%
Tr1w
-1.47%
Tr3m
-4.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 9.7B
Operating Income Growth
1.78
Operating Income Growth Q
-7.22
Operating Income Growth3 Y
-4.91
Operating Income Growth5 Y
4.47
Operating margin
20.49

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
1,083,780,676%
Net Borrowing
1,504,000,000
Shares Insiders
0.02%
Shares Institutions
47.53%
Shares Qo Q
-0.7%
Shares Yo Y
-2.73%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

61
MetricValue
Adjusted FCF
EUR 8.3B
Average Volume
3,852.5x
Bv Per Share
60.46
CAPEX
EUR -1.8B
Ch10y
4.17
Ch15y
32.64
Ch1m
-9.1
Ch1w
-6.68
Ch1y
-20.59
Ch3m
-9.19
Ch3y
-27.4
Ch5y
-14.39
Ch6m
-14.53
Change
-1.43%
Change From Open
-0.54
Close
74.08
Days Gap
-0.89
Depreciation Amortization
3,124,000,000
Dollar Volume
215,847.1
Earnings Date
2026-04-23
EBIT
EUR 9.7B
EBITDA
EUR 12.8B
EPS
EUR 6.2
F Score
5
FCF
EUR 8.6B
FCF EV Yield
8.36x
Financing CF
-9,142,000,000
Fiscal Year End
December
Founded
1,994
Graham Number
92.80223
Graham Upside
27.09
Income Tax
EUR 982M
Investing CF
-3,949,000,000
Is Primary Listing
0
Last Earnings Date
2026-04-23
Last Report Date
2026-03-31
Lynch Fair Value
EUR 31.44
Lynch Upside
-56.94
Ma150
82.02
Ma150ch
-10.98%
Ma20
78.98
Ma20ch
-7.54%
Net CF
-2,447,000,000
Next Earnings Date
2026-07-30
Open
73.42
P FCF Ratio
10.23
P OCF Ratio
8.49
Payment Date
2026-05-07
Position In Range
39.39
Ppne
11,674,000,000
Price Date
2026-05-08
Price EBITDA
EUR 6.84
Ptbv Ratio
23.57
Relative Volume
0.79x
Revenue
47,354,000,000x
SBC By Revenue
0.66x
Share Based Comp
313,000,000
Tax By Revenue
2.07x
Tax Rate
16.83%
Tr6m
-9.75%
Volume
2,956
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

BIT/1SAN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+5.3%
$4.12 annual per share
Payout ratio
+63.2%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+5.2%
2 consecutive years of growth
Total shareholder yield
+8.0%
Next ex-dividend date: 2026-05-05
Performance

BIT/1SAN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-12.5%
S&P 500 1Y: n/a
3Y total return
-13.6%
S&P 500 3Y: n/a
5Y total return
+6.0%
S&P 500 5Y: n/a
10Y total return
+63.3%
S&P 500 10Y: n/a
Ownership

Who owns BIT/1SAN?

Insider, institutional, and short-interest positioning.

Institutional ownership
+47.5%
Share of float held by funds and institutions
Insider ownership
+0.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-2.7%
Negative means the company is buying back shares.
Technical

BIT/1SAN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
32.3
Neutral momentum band
Price vs 200-day MA
-11.1%
50/200-day relationship not available
Beta (5Y)
0.28
Less volatile than the market
Sharpe ratio
-0.49
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BIT/1SAN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bit/1SAN stock rating?

bit/1SAN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bit/1SAN analysis?

The full report lives at /stocks/bit/1SAN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bit/1SAN?

The latest report frames bit/1SAN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bit/1SAN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

bit/1SAN stock profile: metrics, valuation and analysis | StockMarketAgent.AI